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Abstract
Background: Acquisition of human immunodeficiency virus type 1 (HIV-1) infection is mediated by a combination of
characteristics of the infectious and the susceptible member of a transmission pair, including human behavioral and genetic
factors, as well as viral fitness and tropism. Here we report on the impact of established and potential new HLA class I
determinants of heterosexual HIV-1 acquisition in the HIV-1-exposed seronegative (HESN) partners of serodiscordant
Zambian couples.
Methodology/Principal Findings: We assessed the relationships of behavioral and clinically documented risk factors, index
partner viral load, and host genetic markers to HIV-1 transmission among 568 cohabiting couples followed for at least nine
months. We genotyped subjects for three classical HLA class I genes known to influence immune control of HIV-1 infection.
From 1995 to December 2006, 240 HESNs seroconverted and 328 remained seronegative. In Cox proportional hazards
models, HLA-A*68:02 and the B*42-C*17 haplotype in HESN partners were significantly and independently associated with
faster HIV-1 acquisition (relative hazards=1.57 and 1.55; p=0.007 and 0.013, respectively) after controlling for other
previously established contributing factors in the index partner (viral load and specific class I alleles), in the HESN partner
(age, gender), or in the couple (behavioral and clinical risk score). Few if any previously implicated class I markers were
associated here with the rate of acquiring infection.
Conclusions/Significance: A few HLA class I markers showed modest effects on acquisition of HIV-1 subtype C infection in
HESN partners of discordant Zambian couples. However, the striking disparity between those few markers and the more
numerous, different markers found to determine HIV-1 disease course makes it highly unlikely that, whatever the influence
of class I variation on the rate of infection, the mechanism mediating that phenomenon is identical to that involved in
disease control.
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Introduction
In sub-Saharan Africa, heterosexual exposure accounts for
much of the spread of human immunodeficiency virus type 1
(HIV-1) infection, especially among HIV-1 discordant couples [1].
Epidemiological evidence suggests that acquisition of HIV-1
infection is often mediated by risk behaviors (exposure), viral
characteristics (subtypes and co-receptor tropism), coinfection with
other pathogens [2], and host genetic variations that mediate
innate and adaptive immune responses [3,4]. Longitudinal studies
in Lusaka, Zambia have attested to the role of several factors in the
index partner as determinants of HIV-1 transmission within HIV-
1 discordant couples, namely HIV-1 viral load (VL) [5,6], genital
ulcer or inflammation (GUI) [6,7], and certain polymorphisms in
HLA class I genes (HLA A*36, B*57 and C*18) [6]. For the
susceptible HIV-1 exposed seronegative (HESN) heterosexual
partners, major involvement of human genetic variants other than
those in CCR5 receptor/ligand system have been less firmly
established [3,8]. Few investigations have included relatively large
numbers of paired index and susceptible partners, followed them
for long enough, and included sufficient detail to allow persuasive
tests of immunogenetic hypotheses.
Human leukocyte antigen (HLA) class I genes in the major
histocompatibility complex (MHC) are important determinants of
effective immune surveillance. Their allelic variants have been
associated with various outcomes in the natural course of HIV-1
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23469infection, including viremia and disease progression (time to
manifest immunodeficiency after infection) [9,10,11,12,13,14,15].
Favorable HLA alleles like HLA-B*57 and B*27 have strong and
durable impact on both early and late outcomes including set-
point VL [6,16,17,18,19,20,21,22], and they appear to reduce or
delay viral transmission by suppressing viremia in an infected
potential transmitter (e.g., a sexual partner) [6,21]. In contrast,
evidence that HLA variants influence acquisition in HESNs is less
convincing; associations reported for various class I alleles (A*23,
A*68:02, A*74 and B*18) have been less consistent in studies of
mother-infant pairs [23,24], commercial sex workers [25,26,27]
and other high-risk groups [28]. Occasional detection of HIV-1-
specific cytotoxic T-lymphocytes (CTLs) in genital mucosa of
HESNs [29] has been taken to imply a role for HLA class I alleles
in preventing viruses from disseminating and inducing systemic
antibody responses, but multiple studies have not shown enough
consistency to establish unequivocally the involvement of HLA
class I polymorphisms in variable susceptibility to HIV infection
[30]. Here in a large cohort of serodiscordant Zambian couples we
further document influences of HLA class I alleles on the rate of
HIV-1 acquisition that are disparate from those that control
viremia.
Results
Overall characteristics of HIV-1 discordant Zambian
couples in this study
We analyzed 568 HIV-1 serodiscordant couples with complete
HLA class I genotyping as well as adequate follow-up between
1995 and 2006 (Figure 1). These couples included 240 who
seroconverted (SCs) with viruses (predominantly subtype C) closely
linked to those found in their index partners and 328 susceptibles
who were persistently HESN (pHESN) during quarterly follow-up
visits. The pHESNs differed from SCs in sex ratio (p=0.0002), age
(p=0.014 for men and p=0.004 for women), time of follow-up
from enrollment (p,0.0001), and behavioral and clinical risk
scores (p,0.0001) (Table 1). Mean VL was higher in male than in
female index partners (p,0.0001). Other characteristics, including
enrollment date, cohabitation time and age difference between the
man and the woman within a partnership, were highly
comparable between SCs and pHESNs (data not shown).
Therefore, VL of index partner, age and gender of HESN, and
risk score were included as covariates in primary analyses of HIV-
1 acquisition.
Selective testing of HLA markers with previously
reported and newly detected associations
We first examined all HLA class I alleles or haplotypes
implicated in HIV-1 infection or disease control in earlier studies
of associations in Africans by both Cox proportional hazards and
logistic regression analysis (Table 2, Group I). Two markers,
A*68:02 and one or both of the virtually inseparable alleles in the
B*42-C*17 haplotype, were associated with increased likelihood or
rate of acquisition (p,0.05). Only the A*68:02 association
withstood analysis for false discovery rate (FDR, q=0.025 for
Cox proportional hazards model and q=0.050 for logistic
regression model). The unfavorable effects of these markers here
contrast starkly with their apparent protective roles previously
reported: for A*68:02 against infection in another African
population [26] and for the B*42-C*17 haplotype with lower
viremia in both our and other cohorts [31,32].
Three additional markers involving HLA-B that have occasion-
ally been implicated in studies of HIV-1 disease control in other
populations but not in Zambians showed associations with
acquisition of infection here with nominal p#0.05: B*44 and
either B*51 or the B*51-C*16 haplotype with lower risk
(ORs=0.52 and 0.37 or 0.33, respectively) and B*14 with higher
risk (OR=1.79) (Table 2, Group II). However, the statistical
significance of those three markers exceeded the FDR threshold
(all q$0.2). No other variant previously associated with control of
viremia [20] or transmission from the index partner [6] in
Zambians and no other variant associated with acquisition in other
cohorts (e.g., A*23 and B*18) [24,25] appeared to influence the
acquisition of HIV-1 infection in Zambian couples.
No other HLA class I allele that has been reproducibly found to
influence HIV-1 infection or disease progression showed a
corresponding association with HIV-1 acquisition in the full
cohort of discordant Zambian couples (Table 2, Group III). Only
in the subset of couples with female HESNs was there a suggestion
that the African allele A*74:01, recently recognized in association
with both lower VL and decreased likelihood of HIV-1 infection
[20,22,28,33,34], was associated with slower rate of acquisition
(adjusted univariate RH=0.49, p=0.04) (data not shown). The
significance of this association was above the FDR threshold
(q=0.57). Although each comparison was adjusted for age and
gender, this adjustment did not alter any of the associations.
Ten HLA class I supertypes were also analyzed in both Cox
proportional hazards and logistic regression models. None of the
10 showed statistically significant effects on time to infection or on
overall occurrence of infection by the end of study period (Table
S1). A specifically designated portion of the A2 supertype, A02/
A6802, was previously reported to retard acquisition [26];
however, here it was associated with accelerated acquisition
(RH=1.43, p=0.013 and q=0.165), and this effect was due
entirely to the contribution of A*68:02, the dominant allele in this
supertype (85 of 137 with the supertype).
HLA-A*68:02 and B*42-C*17 as independent correlates of
HIV-1 acquisition
All alleles and haplotypes in Table 2 were further analyzed in
multivariable Cox proportional hazards models with stepwise
elimination. These models dismissed several probable or suspected
HLA factors, including (i) B*57, B*81, and C*18 in index partners,
(ii) B*14, B*44, B*81, B*51, and C*18 in HESNs (adjusted p$0.05
for all). In the end, only A* 68:02 and B*42-C*17 in HESNs and
A*36 in index partners retained statistical significance (adjusted
relative hazards, RH=1.76, 1.46 and 2.06; p=0.0004, 0.025 and
,0.0001, respectively) in a reduced model for comparing time to
HIV-1 acquisition (Table 3, model I). The associations of all three
of these HLA factors were independent of the behavioral, clinical
and biological factors documented for the study population. The
impact of these genetic markers persisted in a model including VL
in index partners (Table 3, model II) as well as a model including
both VL in index partners and risk score in couples (RH=1.57,
1.55 and 1.78; p=0.007, 0.013 and 0.001) (Table 3, model III).
Of the 11 initial HESNs who had both A*68:02 and B*42-C*17,
five seroconverted at a rate similar to that seen with B*42-C*17
alone. The infection-free time among initial HESNs bearing
A*68:02 (median=33 months, 95% confidence interval, CI=21–
45 months) and those bearing B*42-C*17 (median=39 months,
95% CI=27–51 months) contrasted with that among other initial
HESNs bearing neither variant (median=69 months, 95%
CI=51–111 months). During the 11-year study interval, 59.0%
of A*68:02-positive and 51.2% of B*42-C*17-positive initial
HESNs became infected. HESNs with either of those two markers
showed significantly more rapid rates of seroconversion than the
remaining HESNs (p,0.001 by log-rank and Wilcoxon tests)
(Figure 2).
HLA Class I Markers and HIV-1 Acquisition
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23469Figure 1. Selection of Zambian subjects for this study (Panel a) and summary of statistical strategies (Panel b). In all, 568 couples (240
transmission pairs and 328 non-transmission pairs) were eligible (see Table 1). Non-genetic factors included age of HESN, sex, direction of
transmission (M to F or F to M), genital ulcer/inflammation (GUI), and viral load (VL).
doi:10.1371/journal.pone.0023469.g001
Table 1. Selected characteristics of 568 Zambian HIV-1 seropositive (index) partners and their seronegative (HESN) partners at
baseline or during follow-up intervals.
Index partners HESNs
Characteristics at baseline N=568 SCs (n=240) pHESNs (n=328) p value
Sex ratio (M/F) 1.1 (296/272) 0.6 (93/147) 1.2 (179/149) 0.0002
Age (years)
Male (mean 6 SD) 34.667.8 32.367.6 34.868.1 0.014
Female (mean 6 SD) 27.465.9 26.366.2 28.667.2 0.004
Characteristics in most recent 6 months of follow-up
Months of follow-up, Median (IQR) 25.5 (14–47) 18 (9–36) 31.5 (17–56) 0.0001
Behavioral and clinical risk score, Median (IQR) 1 (0–2) 1 (1–2) 1 (0–1) ,0.0001
HIV-1 viral load (log10) in index partner
M, mean 6 SD 4.9360.74 NA NA
F, mean 6 SD 4.4460.84 NA NA
The p values in last column refer to comparisons between seroconverters (SCs) and persistent HIV-1 exposed seronegatives (pHESNs). Behavioral and clinical risk score
includes combination of 1) genital ulcer/inflammation for either index, HESN, or both partners, 2) no circumcision of HESN male, 3) recent pregnancy in HESN female,
and 4) sperm in vaginal fluid in HESN female in most recent 6 month of follow-up. F, female; IQR, interquartile range; M, male; NA, not applicable; SD, standard deviation
of the mean.
doi:10.1371/journal.pone.0023469.t001
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Among HESN partners, 23% had GUI during the 6 months
prior to transmission or the end of follow-up. However, GUI was
not associated with HLA class I variants of interest (Table S2).
Discussion
In a comprehensive analysis of a cohort of HIV-1-serodiscor-
dant couples including the largest known set of transmission pairs,
none of the HLA-B alleles most widely reported to influence
viremia, CD4 count or disease progression in subtype C infection
were associated with occurrence or rate of acquisition of HIV-1
infection in the HESN partners. Specifically, although B*13:02,
B*18, B*45:01, B*57:01-03, B*58:01, B*58:02, and B*81:01 have
all been implicated as determinants of VL in sub-Saharan African
populations [6,19,33], they had no corresponding effect on
acquisition of HIV-1 subtype C infection in Zambians.
One HLA-B allele (B*42:01) that has shown some consistency in
its association with better control of viremia [32,33,35]had a
clearly unfavorable effect on acquisition (Table 1). The B*42-
C*17 haplotype is carried in 18.8% of Zambians. Strong linkage
disequilibrium (LD) between B*42 and C*17 in our study
population (r=0.97) [20] precluded separate analysis of either
B*42 or C*17 alone. However, these two alleles occur frequently
in the A*30-C*17-B*42 haplotype, and the favorable effect of
A*30 seen earlier [20] makes it an unlikely contributor to the
acceleration of infection seen here with the B–C haplotype.
Additional HLA-B alleles (B*14, B*44 and B*51) were
differentially distributed between SCs and pHESNs; however,
their impact diminished with more comprehensive analyses.
Relatively slow disease progression has been documented for
B*51 in individuals infected largely with subtype B [9,17], but that
pattern has not extended to other populations, and association
with lower susceptibility to infection has been inconsistent [36]. At
the population level, mutations in HIV-1 induced by B*51 may
account for viral evolution to fixation in infected individuals, but it
is difficult to predict how such changes in the virus might affect
acquisition in HESNs [37]. Findings with B*14 and B*44 have
been even less consistent across ethnic and viral subtype
boundaries [38,39]. The contributions of these alleles to
susceptibility are unclear and appear to be minor. Taken as a
whole, such strikingly disparate effects of HLA-B alleles on the two
outcome measures (control of VL and susceptibility to infection) in
the same cohort imply that if HLA-B alleles play any substantial
Table 2. Analyses of HLA class I variants previously or presently associated with acquisition or control of HIV-1 infection.
SCs pHESNs Time to infection (Cox model) Logistic regression (SCs vs. pHESNs)
Variants n (%) n (%) RH (95% CI) pqOR (95% CI) pq
Group I A*68:02 51 (21.3) 38 (11.6) 1.67 (1.2–2.3) 0.001 0.025 2.06 (1.3–3.3) 0.002 0.050
B*42-C*17 43 (17.9) 41 (12.5) 1.42 (1.0–2.0) 0.035 0.386 1.52 (1.0–2.4) 0.085 0.236
Group II B*14 36 (15.0) 33 (10.0) 1.40 (1.0–2.0) 0.065 0.386 1.79 (1.0–3.1) 0.037 0.205
B*44 17 (7.1) 41 (12.5) 0.70 (0.4–1.1) 0.161 0.391 0.52 (0.3–1.0) 0.034 0.205
B*51 6 (2.5) 20 (6.1) 0.54 (0.2–1.2) 0.139 0.386 0.37 (0.2–1.0) 0.041 0.205
B*51-C*16 5 (2.1) 18 (5.5) 0.50 (0.2–1.2) 0.121 0.398 0.33 (0.1–1.0) 0.036 0.205
Group III A*01 5 (2.1) 17 (5.2) 0.45 (0.2–1.1) 0.075 0.398 0.37 (0.1–1.1) 0.055 0.229
A*02 55 (22.9) 95 (29.0) 0.81 (0.6–1.1) 0.172 0.391 0.74 (0.5–1.1) 0.137 0.302
A*23 60 (25.0) 79 (24.1) 1.08 (0.8–1.5) 0.612 0.805 1.02 (0.7–1.5) 0.927 0.927
A*36 32 (13.3) 30 (9.2) 1.21 (0.8–1.8) 0.316 0.573 1.66 (1.0–2.8) 0.070 0.236
A*68:01 6 (2.5) 14 (4.3) 0.76 (0.3–1.7) 0.514 0.756 0.66 (0.2–1.8) 0.411 0.642
A*74:01 28 (11.7) 45 (13.7) 0.83 (0.6–1.2) 0.344 0.573 0.79 (0.5–1.3) 0.385 0.642
B*18 22 (9.2) 29 (8.8) 1.06 (0.7–1.7) 0.792 0.923 1.06 (0.6–1.9) 0.853 0.927
B*35 15 (6.3) 23 (7.0) 0.86 (0.5–1.4) 0.584 0.805 0.96 (0.4–2.1) 0.917 0.927
B*53 55 (22.9) 57 (17.4) 1.01 (0.8–1.4) 0.955 0.992 1.39 (0.9–2.1) 0.126 0.302
B*57 20 (8.3) 30 (9.2) 0.83 (0.5–1.3) 0.432 0.675 0.91 (0.5–1.7) 0.756 0.899
B*5703 13 (5.4) 23 (7.0) 0.76 (0.4–1.3) 0.327 0.573 0.75 (0.4–1.6) 0.444 0.653
B*5801 17 (7.1) 30 (9.2) 0.67 (0.4–1.1) 0.106 0.386 0.75 (0.4–1.4) 0.366 0.642
B*5802 29 (12.1) 37 (11.3) 1.07 (0.7–1.6) 0.722 0.903 1.08 (0.6–1.8) 0.775 0.899
B*81 16 (6.7) 19 (5.8) 1.00 (0.6–1.7) 0.992 0.992 1.10 (0.5–2.2) 0.791 0.899
C*04 86 (35.8) 94 (28.7) 1.03 (0.8–1.4) 0.812 0.923 1.38 (1.0–2.0) 0.084 0.236
C*18 27 (11.3) 41 (12.5) 0.81 (0.5–1.2) 0.305 0.573 0.85 (0.5–1.4) 0.539 0.749
B*142C*08 33 (13.8) 32 (9.8) 1.33 (0.9–1.9) 0.130 0.386 1.37 (0.8–2.3) 0.251 0.483
B*442C*04 12 (5.0) 18 (5.5) 0.95 (0.5–1.7) 0.866 0.941 0.89 (0.4–1.9) 0.762 0.899
A*30+C*03 13 (5.4) 28 (8.5) 0.65 (0.4–1.1) 0.135 0.386 0.60 (0.3–1.2) 0.145 0.302
Analyses are based on 240 seroconverters (SCs) and 328 the persistent HIV-1 exposed seronegatives (pHESNs). Group I HLA variants include those associated with time
to HIV-1 acquisition in both univariate and multivariable models (Table 3). Group II has variants that are rejected by multivariable models (adjusted p.0.050). Other
variants under Group III have been highlighted in earlier studies relevant to heterosexual HIV-1 acquisition and/or immune control of infection. Variants highly relevant
to Zambians are underlined. Age and gender are treated as covariates in all analyses. The q values correspond to false discovery rates.
doi:10.1371/journal.pone.0023469.t002
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PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23469Figure 2. Kaplan-Meier plots for HIV-1 acquisition among 568 Zambian initial HESNs stratified by HLA-A*68:02 and B*42-C*17. Of
the 11 individuals with both A*68:02 and B*42-C*17, five acquired HIV-1 at rates similar to those in carriers of B*42-C*17 alone; these 11 were treated
as part of the B*42-C*17 group. Differences in acquisition-free time among the three HLA subgroups were tested for significance by the log-rank and
Wilcoxon methods. Estimates of relative hazards (RH) of HIV-1 acquisition are based on Cox proportional hazards models. The numbers of subjects
remaining at-risk at successive follow-up intervals are tabulated below the Kaplan-Meier plots. The seroconversion rate does not reflect the overall
rate in the entire ZEHRP cohort, because couples in this study were selected for clinical and behavioral HIV-1 risk characteristics.
doi:10.1371/journal.pone.0023469.g002
Table 3. Association of HLA class I variants with HIV-1 acquisition in multivariable models including only genetic variables or
behavioral and biologic risk indicators.
All couples MTF couples FTM couples
RH 95% CI P RH 95% CI P RH 95% CI P
Model I
A*68:02 in HESNs 1.76 1.3–2.4 0.0004 1.75 1.2–2.5 0.004 1.47 0.8–2.6 0.185
B*422C*17 in HESNs 1.46 1.1–2.0 0.025 1.49 1.0–2.3 0.068 1.54 0.9–2.6 0.116
A*36 in index partners 2.06 1.5–2.9 ,0.0001 1.52 0.9–2.6 0.115 3.00 1.9–4.9 ,0.0001
Model II
A*68:02 in HESNs 1.78 1.3–2.5 0.0004 1.80 1.2–2.7 0.003 1.60 0.9–2.8 0.109
B*422C*17 in HESNs 1.50 1.1–2.1 0.020 1.53 1.0–2.4 0.066 1.68 1.0–2.9 0.059
A*36 in index partners 1.78 1.3–2.5 0.001 1.39 0.8–2.4 0.226 2.39 1.5–3.9 0.001
VL in index partners 1.77 1.5–2.2 ,0.0001 1.48 1.1–1.9 0.005 1.96 1.4–2.7 ,0.0001
Model III
A*68:02 in HESNs 1.57 1.1–2.2 0.007 1.38 1.0–2.1 0.122 1.48 0.8–2.7 0.180
B*422C*17 in HESNs 1.55 1.1–2.2 0.013 1.75 1.1–2.8 0.017 1.38 0.8–2.4 0.242
A*36 in index partners 1.78 1.3–2.5 0.001 1.53 0.9–2.6 0.122 2.29 1.4–3.7 0.001
VL in index partners 1.81 1.5–2.2 ,0.0001 1.38 1.1–1.8 0.018 1.83 1.3–2.5 0.0001
Risk score
1 1.39 1.0–2.0 0.082 2.01 1.3–3.1 0.001 2.48 0.7–8.2 0.136
2 3.58 2.5–5.2 ,0.0001 4.73 2.9–7.7 ,0.0001 7.62 2.3–24.9 0.001
$3 5.42 3.4–8.7 ,0.0001 4.21 2.2–7.9 ,0.0001 16.70 4.7–58.8 ,0.0001
Abbreviations are defined in Table 1. Associations are tested using Cox proportional hazards models. In model III, each level of positive risk score is compared to the
level in the reference group with a neutral score (zero).
doi:10.1371/journal.pone.0023469.t003
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convincingly documented mechanism by which those alleles
mediate CTL response to specific viral epitopes during the course
of subtype C infection is unlikely to represent the dominant
mechanism regulating heterosexual acquisition.
As for HLA-A alleles, only the relatively recently investigated
African HLA-A*74:01 has shown a comparably favorable effect
on both VL in HIV-infected individuals [20,22,33] and
acquisition among Tanzanians [28] as well as in HESN Zambian
women in our study. Its linkage disequilibrium (LD) with B*57
could not explain the association with slower acquisition in
Zambian women because the latter allele showed no such effect
in the absence of A*74:01. This HLA-A allele does not show
predominant LD with any particular HLA-C allele, but its pattern
of LD in the class I region raises the possibility that it tags a
variant involved in one of the natural killer cell pathways. The
findings for A*74:01 across populations of African ancestry merit
further investigation.
The strongest association seen among Zambian HESNs with
any class I allele was between HLA-A*68:02 and accelerated HIV-
1 acquisition. The relationship was opposite to the protective
association previously reported with this allele as part of the A02
supertype in Kenyan commercial sex workers heavily exposed to
HIV-1 subtype A [23,26]. A*68:02 also appeared to be associated
with relative resistance to HIV-1 subtype B infection among men
of European ancestry [40]. Differential effects in the setting of
different viral subtypes could explain these discrepant associations.
A haplotype effect would be another possible reason for the
population-specific findings. However, in Zambians A*68:02 is
found most frequently in the A*68:02-C*03-B*15 haplotype–but
in only 5% of HESNs and not in tight LD. Regardless of the
population-specific findings, if there is a biologic basis for the
association of A*68:02 with susceptibility to subtype C infection in
Zambians, a similarly unfavorable relationship has not been
reported for viremia or disease control with any HIV-1 subtype.
Conversely, A*36 in HESN Zambians did not contribute to the
acquisition of infection, even though this allele was associated with
both higher VL in their index partners and accelerated viral
transmission from them to their HESN partners [6,20]. Thus, for
both of these HLA-A alleles our data suggest that the mechanisms
underlying immune control of viremia and acquisition of HIV-1
infection are indeed distinct [6,21].
Our earlier analysis of killer immunoglobulin-like receptor
(KIR) genes has revealed some evidence that genetic associations
with HIV-1 transmission may operate indirectly through prom-
inent cofactors (e.g., coinfections). Specifically, KIR2D4*001 as an
unfavorable marker in the Zambian cohort had dual associations
with HIV-1 transmission by index partners and genital ulcer in
index partners [41]. Genital ulcers and inflammation (GUI) also
represent a prominent cofactor for HIV-1 acquisition by HESNs,
but the HLA class I variants highlighted here had no appreciable
impact on GUI; that is, GUI could not have significantly
confounded the observed HLA effects on HIV-1 acquisition.
The frequency of HLA-B supertypes has been inversely related
to the degree of HIV-1 disease control in infected individuals of
European and of African ancestry [22,42,43]. However, our
analyses excluded any substantial contribution by either HLA-A or
HLA-B supertypes to HIV-1 acquisition in Zambians. As with the
individual alleles, our data imply that the differences in peptide-
binding patterns captured by supertype clustering do not influence
acquisition of HIV-1 infection in the way they do HIV-1 disease
control.
These findings could have important implications for the design
of CTL-based vaccines. The evidence for the occurrence of CTL
responses in HESNs has been inconsistent [44,45,46]. However,
even if it could be conclusively shown that HLA allele-specific
CTL responses differentially promote or retard acquisition of
infection, the profile of the genetic polymorphisms that enhance or
impede that process appears to be so different from the profile of
those controlling post-seroconversion immunologic events that the
strategies for designing CTL-based prophylactic and therapeutic
vaccines would almost surely have to diverge along those lines
[30].
In summary, our data indicate that variation according to
individual HLA-A, -B and –C alleles in HESNs and, by
implication, whatever differential CTL responses may be mediated
by those different alleles, fail to explain much if any variation in
resistance to infection among Zambian partners exposed to HIV-1
subtype C. Of course, these disparate results for individual alleles
do not preclude possible contributions of class I molecules by any
of several alternative mechanisms. These alternatives include
differential interaction of class I proteins with non-classical class I
molecules [47,48] receptors in NK cell pathways [49,50],
chaperones [51], T-cell receptors [52], and immunoglobulin-like
transcript 4 molecules [53]. Hopefully, the context of cohabiting
serodiscordant couples will afford further opportunity to elucidate
the distinctive roles of HLA class I polymorphism in acquisition of
HIV-1 infection and in disease control.
Materials and Methods
Ethics Statement
This study followed the human experimentation guidelines of
the United States Department of Health and Human Services, and
all enrolled patients provided written informed consent. The work
presented here was further approved by Institutional Review
Boards at University of Alabama at Birmingham, on a yearly basis.
Study Population
From 1995 through 2006 in the Zambia-Emory HIV Research
Project (ZEHRP) we prospectively evaluated cohabiting HIV-1
serodiscordant couples consisting of a seropositive index partner
and an HESN partner. The procedures for participant recruit-
ment, counseling, quarterly follow-up, clinical examination (for
genital ulcer/inflammation) and laboratory testing (for HIV-1
serology and viral load) have been described elsewhere
[5,54,55,56]. All couples whose HESN partner acquired
virologically linked HIV-1 from the known index partner during
follow-up were included in this study. Non-transmitting couples
were selected on the basis of behavioral or clinical measures of
sexual exposure. To concentrate on the level of increased risk
experienced by each couple during the most recent six months of
follow-up, we cumulated known predictors of risk for heterosex-
ual transmission present at the two most recent quarterly visits
[circumcision, genital ulcer/inflammation (GUI) by history or
examination, pregnancy, and sperm in vaginal fluid] in a
composite risk score. Although average risk scores were lower
in the non-transmitting couples available for study than in
transmitting couples, we disproportionally sampled non-transmit-
ting couples with greater exposure to risk predictors. For
transmitting couples, viruses detected in seroconverters had to
be similar to those present in their cohabiting index partners by
phylogenetic analysis of subgenomic HIV-1 sequences corre-
sponding to gag, env and the long terminal repeat regions [5,57].
Couples with unlinked or ambiguous viruses or inadequate
follow-up time (,9 months) or missing information were
excluded. Through December 2006, 568 couples became eligible
for analyses (Figure 1).
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Methods for HLA class I genotyping have been described
elsewhere [6,20]. In brief, genomic DNA extracted from buffy
coats or whole blood was used for PCR with sequence-specific
primers (SSP) (Dynal/Invitrogen, Brown Deer, WI), sequence-
specific oligonucleotide (SSO) probe hybridization (Innogenetics,
Alpharetta, GA), and sequencing-based typing (SBT) (Abbott
Molecular, Inc., Des Plaines, IL). Most HLA class I alleles were
defined to 4-digit specificities. HLA haplotypes and supertypes
were assigned using the expectation-maximization (EM) algorithm
in SAS Genetics (SAS Institute, Cary, NC) [6,20].
Supertype assignment
HLA class I supertypes were assigned according to previous
classification and a recent update [22,43,58] designating four
HLA-A supertypes (A01, A02, A03 and A24) and six HLA-B
supertypes (B07, B08, B27, B44, B58 and B62). For analytic
purposes here A*3001 and A*2902 were left unclassified along
with other unclassified supertypes according to the previous
framework [58]. For comparison with previous studies we also
clustered several related HLA-A alleles into a supertype designated
A02/6802 [40].
Statistical Analysis
Earlier analyses of the Zambian cohort have addressed various
aspects of HIV-1 transmission and VL [5,6,20,54,55,56]. Here, we
focused on deciphering the role of HLA class I variants [2- and 4-
digit allele levels (Figure 1b), haplotypes, and supertypes] in HIV-
1 acquisition among Zambian HESNs. Statistical software
packages in SAS 9.2 with SAS/Genetics (SAS Institute Inc.,
Cary, NC) were used for all analyses. We first assessed non-genetic
factors, including age, gender, risk score, direction of HIV-1
transmission (male-to-female and female-to-male) and index
partner viral load (VL) (Table 1). Distribution of class I alleles
were evaluated for a) Hardy-Weinberg equilibrium (HWE), b)
association with time to HIV-1 acquisition (Cox proportional
hazards models and Kaplan-Meier plots), c) association with HIV-
1 infection status at the end of follow-up (logistic regression
models). Kaplan-Meier plots illustrate differences in transmission
associated with specific genetic markers; because non-transmitting
couples with relatively higher frequencies of risk predictors were
selectively included, these transmission rates do not reflect rates in
the entire prospectively observed discordant couple population in
Zambia. The overall annual HIV-1 seroincidence (7–9/100 PY)
represents a one-half to two-thirds reduction in transmission
following the introduction of joint testing and counseling [1].
Multivariable analysis highlighted genetic and non-genetic
factors that showed independent associations with HIV-1
acquisition, after stepwise elimination (p.0.05) of probable or
suspected HLA factors. In light of the multiple comparisons
performed, we also calculated a false discovery rate q value for all
HLA variants formally tested in univariate models (Table 2) [59].
Alleles with q,0.2 received further consideration, as suggested by
earlier work [60].
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Table S1 Lack of association between HLA class I
supertypes and HIV-1 acquisition among 568 Zambians
cohabiting with HIV-1 seropositive partners.
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Table S2 Lack of association between HLA class I
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